User: Guest  Login
Document type:
Zeitschriftenaufsatz
Author(s):
Cohen, Ezra E W; Soulières, Denis; Le Tourneau, Christophe; Dinis, José; Licitra, Lisa; Ahn, Myung-Ju; Soria, Ainara; Machiels, Jean-Pascal; Mach, Nicolas; Mehra, Ranee; Burtness, Barbara; Zhang, Pingye; Cheng, Jonathan; Swaby, Ramona F; Harrington, Kevin J; Acosta-Rivera, Mirelis; Adkins, Douglas R.; Aghmesheh, Morteza; Ahn, Myung-Ju; Airoldi, Mario; Aleknavicius, Eduardas; Al-Farhat, Yousuf; Algazi, Alain P.; Almokadem, Salah; Alyasova, Anna; Bauman, Jessica R.; Benasso, Marco; Berrocal, Alfon...     »
Title:
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
Journal title:
The Lancet
Year:
2019
Journal volume:
393
Journal issue:
10167
Pages contribution:
156-167
Fulltext / DOI:
doi:10.1016/s0140-6736(18)31999-8
Publisher:
Elsevier BV
E-ISSN:
0140-6736
Date of publication:
01.01.2019
 BibTeX